Your browser doesn't support javascript.
loading
ABSTRACT

BACKGROUND:

More than 100,000 patients have been treated, since the implementation of the National Universal Coverage for antiretroviral therapy (ART) in Thailand Although there are several comprehensive guidelines available internationally, there is a need to have guidelines that can be implemented in Thailand. MATERIAL AND

METHOD:

The guidelines were developed by a panel of 17 members who are the experts on HIV research and/or HIV patient care and appointed without incentive by the Thai AIDS Society (TAS). The recommendations were based on evidences from the published studies and availability of antiretroviral agents. Published studies that are relevant and applicable to Thailand in particular have been taken into consideration.

RESULTS:

The recommendations include when to start ART; what to start; how to monitor the therapy; adverse effects and its management; diagnosis of treatment failure; and antiretroviral treatment options in patients with treatment failure. ART in special circumstances, i.e., patients with co-infection of tuberculosis or hepatitis B virus, is also included Appropriate level of CD4+ T-cell count to start ART among Thai patients has been considered carefully. The authors recommend to start ART at CD4+ T-cell count < 200 cells/mm3.

CONCLUSION:

ART should be initiated in adults and adolescents HIV-1 infected patients with a history of HIV-related illness or AIDS or with a CD4+ T-cell count <200 cells/mm3. For treatment-naive patients, the preferred initial therapy is a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen. CD4' T-cell count and viral load should be monitored for at least twice and once a year, respectively. Proper management of antiretroviral-related toxicity and enhancement of adherence are crucial for the long-term success of ART.
Asunto(s)
Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Sociedades Médicas / Tailandia / Humanos / Infecciones por VIH / VIH-1 / Monitoreo de Drogas / Recuento de Linfocito CD4 / Fármacos Anti-VIH / Antirretrovirales Tipo de estudio: Guía de Práctica Clínica País/Región como asunto: Asia Idioma: Inglés Año: 2008 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Sociedades Médicas / Tailandia / Humanos / Infecciones por VIH / VIH-1 / Monitoreo de Drogas / Recuento de Linfocito CD4 / Fármacos Anti-VIH / Antirretrovirales Tipo de estudio: Guía de Práctica Clínica País/Región como asunto: Asia Idioma: Inglés Año: 2008 Tipo del documento: Artículo